Qlife Holding AB (OSTO:QLIFE) Common Stock : kr51.63 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Common Stock?

Qlife Holding AB's quarterly common stock increased from Mar. 2023 (kr1.85 Mil) to Jun. 2023 (kr51.63 Mil) but then stayed the same from Jun. 2023 (kr51.63 Mil) to Sep. 2023 (kr51.63 Mil).

Qlife Holding AB's annual common stock increased from Dec. 2020 (kr0.89 Mil) to Dec. 2021 (kr1.24 Mil) and increased from Dec. 2021 (kr1.24 Mil) to Dec. 2022 (kr1.85 Mil).

Qlife Holding AB Common Stock Historical Data

The historical data trend for Qlife Holding AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Common Stock Chart

Qlife Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Common Stock

0.54

0.89

1.24

1.85

Qlife Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Common Stock	Get a 7-Day Free Trial														1.24	1.85	1.85	51.63	51.63

Qlife Holding AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Qlife Holding AB (OSTO:QLIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

4HG:Germany

Address

Redaregatan 48, Helsingborg, SWE, SE-252 36

Website

https://www.qlifeholding.com

Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines